
---
title: '方盛制药：头孢克肟片通过仿制药一致性评价'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=2675'
author: 证券时报网
comments: false
date: Tue, 08 Mar 2022 16:58:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=2675'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603998" style="color: #2f67d1;text-decoration: none;" code="603998" target="_blank">方盛制药</a>(603998)3月8日晚间公告，公司收到国家药监局下发的关于头孢克肟片的《药品补充申请批准通知书》，确认该药品通过仿制药质量和疗效一致性评价。</p>

                  
</div>
            